BIANCONI, MARISTELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.926
EU - Europa 1.382
AS - Asia 1.178
SA - Sud America 372
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.967
Nazione #
US - Stati Uniti d'America 2.878
SG - Singapore 392
BR - Brasile 307
IT - Italia 264
VN - Vietnam 224
CN - Cina 213
RU - Federazione Russa 205
UA - Ucraina 199
DE - Germania 129
SE - Svezia 129
TR - Turchia 111
IE - Irlanda 107
FI - Finlandia 82
DK - Danimarca 75
HK - Hong Kong 73
FR - Francia 69
GB - Regno Unito 63
KR - Corea 42
CI - Costa d'Avorio 38
IN - India 36
MA - Marocco 28
BD - Bangladesh 22
CA - Canada 20
MX - Messico 20
AR - Argentina 19
ZA - Sudafrica 17
JP - Giappone 14
NL - Olanda 13
ES - Italia 12
CO - Colombia 11
EC - Ecuador 10
ID - Indonesia 10
BE - Belgio 8
CL - Cile 8
PL - Polonia 8
VE - Venezuela 8
IQ - Iraq 7
MY - Malesia 7
DZ - Algeria 6
TN - Tunisia 5
EU - Europa 4
PK - Pakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
UZ - Uzbekistan 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EG - Egitto 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
TH - Thailandia 1
TV - Tuvalu 1
Totale 5.967
Città #
Ashburn 495
Singapore 251
Chandler 236
Fairfield 217
Jacksonville 206
Dallas 154
Wilmington 137
San Jose 115
Dublin 107
Seattle 98
Centro 96
Boardman 94
Woodbridge 83
New York 80
Houston 76
Ho Chi Minh City 72
Ann Arbor 69
Hong Kong 69
Beijing 59
Cambridge 59
Hanoi 58
Des Moines 51
Los Angeles 50
Moscow 48
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Lauterbourg 38
Abidjan 37
The Dalles 36
Munich 29
Helsinki 23
Turku 21
Orem 20
São Paulo 19
London 17
San Diego 17
Hefei 15
Tokyo 14
Atlanta 13
Chennai 13
Chicago 13
Buffalo 11
Johannesburg 11
Pune 10
Rio de Janeiro 10
Frankfurt am Main 9
Izmir 9
Stockholm 9
Brasília 8
Brussels 8
Columbus 8
Council Bluffs 8
Paris 8
Santa Clara 8
Amsterdam 7
Belo Horizonte 7
Da Nang 7
Manchester 7
Montreal 7
Poplar 7
Cagliari 6
Denver 6
Norwalk 6
Porto Alegre 6
San Francisco 6
Santiago 6
Shanghai 6
Warsaw 6
Wuxi 6
Brooklyn 5
Bến Tre 5
Campinas 5
Curitiba 5
Dhaka 5
Fortaleza 5
Guangzhou 5
Guayaquil 5
Kilburn 5
Rome 5
Washington 5
Wuhan 5
Biên Hòa 4
Bogotá 4
Bắc Giang 4
Duque de Caxias 4
Fayetteville 4
Goiânia 4
Guarulhos 4
Haiphong 4
Mexico City 4
Montevideo 4
Mumbai 4
Santo André 4
Ancona 3
Ankara 3
Caxias do Sul 3
City of London 3
Florianópolis 3
Totale 3.813
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 210
Immunotherapy in genitourinary cancers: Where are we going? 205
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 194
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 193
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 177
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 174
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 170
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 164
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 160
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 157
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 155
Adjuvant treatment after surgical resection 153
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 152
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 152
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 152
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 149
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 149
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 147
Panitumumab for the treatment of metastatic colorectal cancer: A review 144
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 143
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 141
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 138
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 134
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 134
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 134
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 133
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 131
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 127
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 127
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 123
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 123
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 123
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 122
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 112
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 103
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 103
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 100
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 97
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 85
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 80
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 65
Totale 6.063
Categoria #
all - tutte 25.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 100 64 29
2021/2022370 35 92 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025833 112 74 10 12 47 29 120 32 139 62 109 87
2025/20262.159 158 226 166 236 293 170 357 199 165 189 0 0
Totale 6.063